Osaic Holdings
CYTK icon

Osaic Holdings’s Cytokinetics CYTK Stock Holding History

Osaic Holdings’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$275 – 7920
2025
Q3 		$275 Hold
1
– – ﹤0.01% 7653
2025
Q2 		$250 Hold
1
– – ﹤0.01% 7472
2025
Q1 		$766 Hold
1
– – ﹤0.01% 6893
2024
Q4 		$1.21K Hold
1
– – ﹤0.01% 6774
2024
Q3 		$1.54K Hold
1
– – ﹤0.01% 6707
2024
Q2 		$1.5K Buy
+1
New +$60 ﹤0.01% 6702

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's CYTK Position: Q2 2026 in Review

Osaic Holdings reduced its Cytokinetics (CYTK) stake by 1.5% in Q2 2026, selling an estimated $56.4K and leaving 50,087 shares worth $4.27M. The position accounts for 0.01% of the portfolio, ranked #1655.

Osaic Holdings first reported a position in CYTK in Q1 2020 and has held it in 26 quarters since. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Osaic Holdings held 50,087 shares of Cytokinetics worth $4.27M as of Q2 2026.
  • Osaic Holdings sold 785 Cytokinetics shares in Q2 2026, an estimated $56.4K.
  • Cytokinetics made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1655 holding.
  • Osaic Holdings first reported a position in Cytokinetics in Q1 2020 and has held it in 26 quarters since.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.